Tenofovir disoproxil fumarateScleromyxedema: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61482-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：349 / 349

相关论文

共 50 条

[31] Tenofovir disoproxil fumarateOsteoporosis and Secondary hyperparathyroidism: case report
[J]. Reactions Weekly, 2023, 1945 (1) : 489 - 489
[32] Tenofovir-disoproxil-fumarateAcquired resistance: case report
[J]. Reactions Weekly, 2021, 1849 (1) : 396 - 396
[33] Tenofovir disoproxil fumarateAcute tubular necrosis: case report
[J]. Reactions Weekly, 2004, 987 (1) : 14 - 15
[34] Tenofovir-disoproxil-fumarateElevation in ALP: case report
[J]. Reactions Weekly, 2020, 1814 (1) : 325 - 325
[35] Emtricitabine/tenofovir disoproxil fumarateFanconi syndrome: case report
[J]. Reactions Weekly, 2012, 1401 (1) : 15 - 16
[36] Emtricitabine/tenofovir disoproxil fumarateInterstitial nephritis: case report
[J]. Reactions Weekly, 2011, 1366 (1) : 14 - 14
[37] Emtricitabine/tenofovir disoproxil fumarateFanconi syndrome: case report
[J]. Reactions Weekly, 2018, 1724 (1) : 154 - 154
[38] Tenofovir-disoproxil-fumarateTreatment failure: case report
[J]. Reactions Weekly, 2021, 1853 (1) : 443 - 443
[39] Emtricitabine/tenofovir disoproxil fumarateRenal impairment: case report
[J]. Reactions Weekly, 2019, 1742 (1) : 94 - 94
[40] Tenofovir disoproxil fumarateRenal impairment and proteinuria: case report
[J]. Reactions Weekly, 2017, 1654 (1) : 325 - 325

← 1 2 3 4 5 →